Return to content in this issue

 

Changes of Thymus and Activation-Regulated Chemokine in Type 2 Inflammatory Disease Patients with Dupilumab Treatment

Zhou B, Liang S, Shang S, Xiang L, Li L

Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China

J Investig Allergol Clin Immunol 2023; Vol. 33(1)
doi: 10.18176/jiaci.0874

Key words: Thymus and activation-regulated chemokine, Type 2 Inflammatory disease, Atopic dermatitis, Dupilumab